This company seems to have been delisted
Reason: Acquired by Pfizer
Last recorded trade on: February 9, 2024
Source: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-completes-acquisition-seagen
Reason: Acquired by Pfizer
Last recorded trade on: February 9, 2024
Source: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-completes-acquisition-seagen
Seagen
SGEN
₹19,919
Share price
-0.07%
Change (1 day)
75.66%
Change (1 year)
Categories
Number of shares outstanding for Seagen (SGEN)
Number of shares outstanding in September 2023 : 188,135,000
According to Seagen 's latest financial reports and stock price the company's current number of shares outstanding is 188,135,000. At the end of 2023 the company had 188,135,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Seagen from 2001 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 0.18 B | 1.1% |
| 2022 | 0.18 B | 1.64% |
| 2021 | 0.18 B | 2.24% |
| 2020 | 0.17 B | 4.33% |
| 2019 | 0.17 B | 7.14% |
| 2018 | 0.16 B | 11.2% |
| 2017 | 0.14 B | 1.55% |
| 2016 | 0.14 B | 1.67% |
| 2015 | 0.13 B | 12.61% |
| 2014 | 0.12 B | 1.15% |
| 2013 | 0.12 B | 2.68% |
| 2012 | 0.11 B | 3.67% |
| 2011 | 0.11 B | 13.44% |
| 2010 | 0.10 B | 0.81% |
| 2009 | 0.10 B | 26.13% |
| 2008 | 79.78 M | 18.23% |
| 2007 | 67.48 M | 32.2% |
| 2006 | 51.05 M | 20.46% |
| 2005 | 42.37 M | 1% |
| 2004 | 41.95 M | 35.31% |
| 2003 | 31 M | 1.82% |
| 2002 | 30.45 M | 5.16% |
| 2001 | 28.96 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 ImmunoGen
IMGN | 273,341,000 | 45.29% | 🇺🇸 USA |
 Biogen BIIB | 146,100,000 | -22.34% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | 66,383,000 | -64.72% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | 201,918,066 | 7.33% | 🇺🇸 USA |
 Pfizer PFE | 5,675,000,000 | 2,916.45% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2,038,500,000 | 983.53% | 🇬🇧 UK |
 AbbVie ABBV | 1,768,000,000 | 839.75% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2,031,000,000 | 979.54% | 🇺🇸 USA |